Researchers identify 'neurostatin' that may reduce the risk of Alzheimer's disease

An approved anti-cancer drug successfully targets the first step in the toxic chain reaction that leads to Alzheimer's disease, suggesting that treatments may be found to lower the risk of developing the neurodegenerative condition.